These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20683038)

  • 1. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
    Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
    Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
    Sandlund J; Oosterwijk E; Grankvist K; Oosterwijk-Wakka J; Ljungberg B; Rasmuson T
    BJU Int; 2007 Sep; 100(3):556-60. PubMed ID: 17608827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
    J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
    Gigante M; Li G; Ferlay C; Perol D; Blanc E; Paul S; Zhao A; Tostain J; Escudier B; Negrier S; Genin C
    Anticancer Res; 2012 Dec; 32(12):5447-51. PubMed ID: 23225450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
    Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.
    Donato DP; Johnson MT; Yang XJ; Zynger DL
    Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
    Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
    J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
    Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
    J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
    Alshenawy HA
    Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comment to "Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression"].
    Salinas AS
    Actas Urol Esp; 2011 Feb; 35(2):87-8. PubMed ID: 21288602
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
    Genega EM; Ghebremichael M; Najarian R; Fu Y; Wang Y; Argani P; Grisanzio C; Signoretti S
    Am J Clin Pathol; 2010 Dec; 134(6):873-9. PubMed ID: 21088149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients.
    Závada J; Závadová Z; Zat'ovicová M; Hyrsl L; Kawaciuk I
    Br J Cancer; 2003 Sep; 89(6):1067-71. PubMed ID: 12966427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.